Skip to main content

Table 1 Clinical and biological characteristics of HCC and liver metastasis patients

From: Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection

  HCC (n = 94) Liver metastasis (n = 14)
Age, yearsa 69 (65–87) 60 (21–85)
Gender (male/female) 70/24 10/4
Plt (×103/μl)a 14.2 (3.1–34.6) 27.8 (81–195)
BMI (kg/m2)a 21.5 (18.5–33.5) 21.7 (19.0–27.5)
Alb (g/dl)a 4.1 (2.8–5.1) 4.4 (3.4–4.8)
T-Bil (mg/dl)a 0.7 (0.3–2.9) 0.8 (0.5–2.1)
AST (U/L)a 36.5 (13–114) 19 (14–62)
ALT (U/L)a 30.9 (9–114) 16 (10–61)
M2BPGi (COI))a 2.79 (0.29–8.75) 0.55 (0.29–3.89)
FIB-4 indexa 4.27 (0.3–13.7) 2.14 (0.34–1.42)
SVR/non-SVR 30/64
Fibrosis (F:0–1/2/3/4) (2/36/39/17) (14/0/0/0)
Inflammation (A:0/1/2/3) (0/17/60/17) (14/0/0/0)
FibroScan (kPa)a 13.9 (2.5–46.4) 5.1 (2.5–8.3)
VTQ (m/s)a 1.79 (0.89–3.45) 1.23 (0.96–1.47)
HCC Stage (I/II/III) (48/35/11)
  1. amedian (range)
  2. Plt platelet count, BMI Body Mass Index, Alb albumin, T-Bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, M2BPGi Mac-2 binding protein glycosylation isomer, SVR sustained viral response, VTQ Virtual-Touch tissue quantification, HCC hepatocellular carcinoma